Endothelial-to-Mesenchymal Transition

2016/04/05 by Kurt R. Stenmark, Maria Frid, Maria G. Frid +1 · 28 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer, Hypoxia, and Metabolism #Pulmonary Hypertension Research and Treatments #Congenital heart defects research

paper · pdf · doi:10.1161/circulationaha.116.022479

Cited by

• Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension
• Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases
• Identification of SNHG11 as a Therapeutic Target in Pulmonary Hypertension
• Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series). [europepmc]
• Vascular Cells in Blood Vessel Wall Development and Disease. [europepmc]
• Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension. [europepmc]
• Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. [europepmc]
• Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled. [europepmc]
• A Metabolic Basis for Endothelial-to-Mesenchymal Transition. [europepmc]
• Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension. [europepmc]
• Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. [europepmc]
• Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases. [europepmc]
• Pharmacological inhibition of β-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression. [europepmc]
• Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension. [europepmc]
• Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension. [europepmc]
• Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis. [europepmc]
• Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension. [europepmc]
• Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis. [europepmc]
• Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension. [europepmc]
• Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application. [europepmc]
• A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular Lesions. [europepmc]
• Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells. [europepmc]
• Single-cell transcriptomic profile of human pulmonary artery endothelial cells in health and pulmonary arterial hypertension. [europepmc]
• Endothelial FGF signaling is protective in hypoxia-induced pulmonary hypertension. [europepmc]
• Endothelial Sphingosine-1-Phosphate Receptor 4 Regulates Blood-Brain Barrier Permeability and Promotes a Homeostatic Endothelial Phenotype. [europepmc]
• The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease. [europepmc]
• Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response. [europepmc]
• Pulmonary Vascular Remodeling in Pulmonary Hypertension. [europepmc]